Publications & Works

Publication Network
Articles 32
All (32)
SCI-E, SSCI, AHCI (23)
SCI-E, SSCI, AHCI, ESCI (28)
ESCI (5)
Scopus (29)
TRDizin (7)
Other Publications (2)

1. 18F-FDG-PET/MRI Demonstration of Extensive Spinal Cord Metastases in a Patient with Ovarian Carcinoma Over Karsinomlu Bir Hastada Yaygın Spinal Kord Metastazlarının 18F-FDG-PET/MRG ile Görüntülenmesi

Güneren C., ASA S., Sayman H. B.
Molecular Imaging and Radionuclide Therapy , vol.35, no.2, pp.142-144, 2026 (ESCI, Scopus, TRDizin) Creative Commons License

2. Beyond MRI: Unveiling metabolic signatures of primary hypophysitis with 18F-FDG PET

ŞAHİN S., Kocaman B. B., Yanmaz M. U., Biyikoglu S. E., Korkmaz O. P., DURCAN E., et al.
Journal of Endocrinological Investigation , 2026 (SCI-Expanded, Scopus) Creative Commons License

3. Integrating functional and volumetric assessments in 90Y radioembolization: added value of [⁹⁹ᵐTc]Mebrofenin scintigraphy

KİBAR A., ASA S., Abuqbeitah M., Aghazada F., Sayman H. B.
Annals of Nuclear Medicine , 2026 (SCI-Expanded, Scopus)

4. Rituximab in the management of retroperitoneal fibrosis: A single tertiary rheumatology care center experience

Oztas M., Altun I., Ayla A. Y., Cerme E., Demirdag C., ASA S., et al.
International Journal of Rheumatic Diseases , vol.26, no.9, pp.1714-1721, 2023 (SCI-Expanded, Scopus)

5. 18F-FDG PET/MRI Image of Skin Metastasis of Ovarian Cancer

KİBAR A., ASA S., Beşli R. L., Sağer M. S., SÖNMEZOĞLU K.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.32, no.2, pp.159-161, 2023 (ESCI, TRDizin) Creative Commons License Sustainable Development

6. Comparison of Whole-Body Ga-68 DOTA TATE Positron Emission Tomography and Magnetic Resonance Imaging in the Detection of Bone Metastasis of Neuroendocrine Tumor in Simultaneous 3T Positron Emission Tomography/Computed Tomography

ASA S., Kibar A., BESLI L. U., Eryürekli A. E., SAMANCI C., SAĞER M. S., et al.
Cerrahpaşa Medical Journal , vol.47, no.1, pp.7-13, 2023 (TRDizin)

7. Bilateral Lymphadenopathy After COVID Vaccine in 18F-Choline PET/MRI Performed for Hyperparathyroidism

Kibar A., Aghazada F., Asa S., Besli R. L., Sonmezoglu K.
CLINICAL NUCLEAR MEDICINE , vol.48, no.3, 2023 (SCI-Expanded, Scopus) Sustainable Development

8. SPECT/CT-based dosimetry of salivary glands and iodine-avid lesions following I-131 therapy

ABUQBEITAH M., DEMİR M., Sager S., ASA S., Isikci N. I., SÖNMEZOĞLU K.
HEALTH AND TECHNOLOGY , vol.13, no.1, pp.101-110, 2023 (ESCI, Scopus) Creative Commons License Sustainable Development

9. Original research patients undergoing multiple F-18-FDG PET/CT scans: frequency, clinical indications, and cumulative dose

ABUQBEITAH M., DEMİR M., Soenmezoglu K., SAYMAN H. B., KABASAKAL L., Sager S., et al.
HEALTH AND TECHNOLOGY , vol.13, no.1, pp.89-97, 2023 (ESCI, Scopus)

10. Simplification of dosimetry in 90Y-radioembolization therapy by dual planar images

Abuqbeitah M., Akdağ Ö. T., DEMİR M., ASA S., SÖNMEZOĞLU K.
BMC cancer , vol.22, no.1, pp.1288, 2022 (SCI-Expanded, Scopus) Creative Commons License

11. Evaluation of treatment efficiency in 301 patients with hyperthyroidism treated with a single dose of I-131 as outpatient

Ince B., Namazova A., Bilgic S., Nazari A., KİBAR A., Aghazada F., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , no.SUPPL 1, 2021 (SCI-Expanded, Scopus)

12. Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT

Asa S., Sönmezoğlu K., Uslu-Besli L., Şahin O. E., Karayel E., Pehlivanoglu H., et al.
ANNALS OF NUCLEAR MEDICINE , vol.35, pp.900-915, 2021 (SCI-Expanded, Scopus) Sustainable Development

13. Comparison of brain F-18 FDG PET/MRI with PET/CT imaging in pediatric patients

Sager G., Akgun E., Abuqbeitah M., Uslu L., ASA S., Akgun M. Y., et al.
CLINICAL NEUROLOGY AND NEUROSURGERY , vol.206, 2021 (SCI-Expanded, Scopus)

14. The role of Ga-68-DOTATATE PET/CT and F-18-FDG PET/CT in the follow-up of patients with medullary thyroid cancer

Sahin O. E., USLU BEŞLİ R. L., Asa S., Sager S., Sonmezoglu K.
HELLENIC JOURNAL OF NUCLEAR MEDICINE , vol.23, no.3, pp.321-329, 2020 (SCI-Expanded, Scopus) Sustainable Development

15. Do Volume-Based and Metabolic 18F FDG PET/CT Parameters Identify Groups at Risk for Poor Prognosis in Patients with Newly Diagnosed Metastatic and Non-Metastatic Non-Small Cell Lung Cancer?

KUPIK O., Bozkurt M., Asa S., Eren G., GÜNDOĞDU H., ARPA M.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.30, no.3, pp.162-170, 2020 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

16. Correlation of SUVmax and Apparent Diffusion Coefficient Values Detected by Ga-68 PSMA PET/MRI in Primary Prostate Lesions and Their Significance in Lymph Node Metastasis: Preliminary Results of an On-going Study

Uslu-Besli L., Bakir B., Asa S., Guner E., Demirdag C., Sahin O. E., et al.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.28, no.3, pp.104-111, 2019 (ESCI, Scopus, TRDizin) Creative Commons License

17. Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma

Sager S., Akgun E., USLU-BESLI L., Asa S., Akovali B., SAHIN O., et al.
NUCLEAR MEDICINE COMMUNICATIONS , vol.40, no.5, pp.461-468, 2019 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

18. Diagnostic capabilities of mri versus18 F FDG PET-CT in postoperative patients with thyroglobulin positive, 131 I-negative local recurrent or metastatic thyroid cancer

Samanci C., Onal Y., Sager S., Asa S., Ustabasioglu F. E., Alis D., et al.
Current Medical Imaging , vol.15, no.10, pp.956-964, 2019 (SCI-Expanded, Scopus) Sustainable Development

19. Comparison of Ga-68 PSMA positron emission tomography/computerized tomography with Tc-99m MDP bone scan in prostate cancer patients

USLU-BESLI L., Sager S., Akgun E., Asa S., Sahin O. E., Demirdag C., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.1, pp.301-310, 2019 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

20. Comparison of day 3 and day 5 thyroglobulin results after thyrogen injection in differentiated thyroid cancer patients

SAGER S., HATIPOGLU E., GUNES B., ASA S., Uslu L., SÖNMEZOGLU K.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM , vol.9, no.6, pp.177-183, 2018 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

21. Karaciğer, safra yolları, safra kesesi ve pankreas malignitelerinde PET/MR görüntüleme

Asa S., Uslu Beşli R. L.
Türkiye Klinikleri , vol.1, pp.222-227, 2017 (Non Peer-Reviewed Journal)

22. The role of FDG-PET/CT in detecting unsuspected and unknown distant metastasis in the initial staging of NSCLC

Halac M., Ozhan M., Yilmaz Aksoy S., Vatankulu B., Aliyev A., Asa S., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.44, no.6, pp.1029-1040, 2014 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

23. The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level

Asa S., AKSOY S. Y., Vatankulu B., Aliyev A., Uslu L., OZHAN M., et al.
ANNALS OF NUCLEAR MEDICINE , vol.28, no.10, pp.970-979, 2014 (SCI-Expanded, Scopus) Sustainable Development

24. Comparison of Tc-99m pertechnetate images with dual-phase Tc 99m MIBI and SPECT images in primary hyperparathyroidism.

Sager S., SHAFIPOUR H., ASA S., YıLMAZ S., TEKSÖZ S., ONSEL C.
Indian journal of endocrinology and metabolism , vol.18, pp.531-6, 2014 (Scopus)

25. Appearance of Recurrent Cardiac Myxofibrosarcoma on FDG PET/CT

ERDOĞAN E. B., Asa S., Aksoy S. Y., Ozhan M., Halac M.
CLINICAL NUCLEAR MEDICINE , vol.39, no.6, pp.559-560, 2014 (SCI-Expanded, Scopus)

26. Uzmanlık Eğitimi’nin Bileşenleri Arasında Oluşturulan Kurumsal İletişim Modeli ve Etkileri

MURT A., ARIKAN A. E., ÇAVDAR S., ASA S., İMAMOĞLU M., ERTAŞ A., et al.
Tıp Eğitimi Dünyası Dergisi , vol.1, no.41, pp.27-35, 2014 (Peer-Reviewed Journal)

27. Multiple cardiac masses and distant metastatic foci in a patient with high grade pleomorphic sarcoma of the heart revealed by follow-up FDG PET/CT

Uslu L., Asa S., Sager S., Halac M.
NUKLEARMEDIZIN-NUCLEAR MEDICINE , vol.53, no.2, 2014 (SCI-Expanded, Scopus)

28. FDG PET/CT in the Detection of Metastases in a Patient With Tg and I-131 WBS Negative Follicular Thyroid Cancer

Aliyev A., Yilmaz S., Ozhan M., Asa S., Halac M.
CLINICAL NUCLEAR MEDICINE , vol.38, no.3, pp.226-227, 2013 (SCI-Expanded, Scopus) Sustainable Development

29. Graft Infection Imaging with FDG and FDG-labeled Leukocytes

Yilmaz S., Asa S., Ozhan M., Halac M.
INTERNAL MEDICINE , vol.52, no.9, pp.1009-1010, 2013 (SCI-Expanded, Scopus) Creative Commons License

30. Appearance of intracranial meningioma in FDG and 68Ga-DOTATOC PET/CT.

YILMAZ S., Ocak M., Asa S., Gülsen F., HALAC M., Kabasakal L.
Revista espanola de medicina nuclear e imagen molecular , vol.32, pp.60-1, 2013 (SCI-Expanded, Scopus)

31. The different distribution patterns of FDG and FDG-labelled WBC in inflammatory and infectious lesions

Yilmaz S., Ocak M., Asa S., Aliyev A., Ozhan M., Halac M., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.39, no.10, pp.1660-1661, 2012 (SCI-Expanded, Scopus)

32. Unilateral thalamic hypometabolism on FDG brain PET in patient with temporal lobe epilepsy.

SAGER S., ASA S., Uslu L., HALAC M.
Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India , vol.26, pp.94-5, 2011 (SCI-Expanded, Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences 11

1. Automated Detection of Pulmonary Embolism Using CT and Perfusion Spectral Images

Tulum G., Osman O., Ipek N., DEMİR M., ASA S., SÖNMEZOĞLU K., et al.
2nd International Conference on Forthcoming Networks and Sustainability in the AIoT Era (FoNeS-AIoT), İstanbul, Turkey, 27 - 29 January 2024, pp.366-377, (Full Text)

2. 18F-FDG PET/BT’NİN ÇOCUK HASTALARDA ENFEKTİF ENDOKARDİT TANISINDAKİ YERİ

Ugan Atik S., Gökalp S., Bilgiç S., Asa S., Ergül Y., Güzeltaş A.
19. ULUSAL PEDİYATRİK KARDİYOLOJİ VE PEDİYATRİK KALP CERRAHİSİ KONGRESİ, İstanbul, Turkey, 23 - 25 October 2020, vol.1, no.8, pp.13-14, (Summary Text) Sustainable Development

3. prostat kanserli Hastalarda prostat Lezyonlarının Degˆerlendirilmesinde ga-68 pSMA peT/BT ile ga-68 pSMA peT/Mr ve Biparametrik Mr go¨ru¨ntu¨lemenin kars¸ılas¸tırılması

USLU BEŞLİ R. L., ASA S., BAKIR B., SAYMAN H. B., SÖNMEZOĞLU K.
30. Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 12 - 14 April 2018, pp.5, (Summary Text) Sustainable Development

4. Du¨s¸u¨k Doz radyoaktif ı-131 Tedavisi Ablasyonda Beklentileri kars¸ılıyor mu?

RAZAVIKHOSROSHAHI S., ŞAHİN O. E., SAĞER M. S., ASA S., USLU BEŞLİ R. L., AKGÜN E., et al.
30. Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 12 - 14 April 2018, pp.21, (Summary Text)

5. Comparison of F18 DOPA and Ga68 DOTA TATE in detection of recurrences or metastasis of medullary thyroid cancer

ASA S., SÖNMEZOĞLU K., AKGÜN E., RAZAVIKHOSROSHAHI S., TEKSÖZ S., OCAK DEMİRCİ E. M., et al.
European Association of Nuclear Medicine Congress 2017, Viyana, Australia, 21 - 25 October 2017, pp.1, (Summary Text) Sustainable Development

6. Prognostic Significance of Metabolic Parameters by 18F-FDG PET/CT in Non-Small Cell Lung Cancer

ASA S.
European Association of Nuclear Medicine Congress 2016, Barcelona, Spain, 15 - 19 October 2017, vol.43, no.1, pp.232, (Full Text) Sustainable Development

7. The Role and Importance of FDG PET/CT in Assessment of Malignancy Focus in Paraneoplastic Neurologic Syndrome

Vatankulu B., ASA S., Sager S., Sayman H. B., Sonmezoglu K., Halac M., et al.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Gothenburg, Sweden, 18 - 22 October 2014, vol.41, (Summary Text)

8. Developing generic skills during residency: A novel specialty-specific approach

MURT A., ARIKAN A. E., ÇAVDAR S., ERTAŞ A., ASA S., İMAMOĞLU M.
AMEE – Colouring outside the lines, Prag, Czech Republic, 24 - 28 August 2013, pp.382, (Summary Text)

9. Uzmanlık Eğitimi’nin bileşenleri arasında oluşturulan kurumsal iletişim modeli ve etkileri

MURT A., ARIKAN A. E., ÇAVDAR S., ASA S., İMAMOĞLU M., ERTAŞ A., et al.
Mezuniyet Sonrası Tıp Eğitimi Sempozyumu, Kocaeli, Turkey, 2 - 03 May 2013, pp.16, (Summary Text)

10. Opere nüks iyi differansiye tiroit papiller kanserli hastalarda Tc-99m Hynic-Tate somatostatin reseptör sintigrafisinin değeri

ASA S.
23. Ulusal Nükleer Tıp, İzmir, Turkey, 27 April - 01 May 2011, pp.32, (Summary Text) Sustainable Development

11. Opere nüks medüller tiroit kanserli hastalarda Tc-99m Hynic-Tate somatostatin reseptör sintigrafisinin değeri

ASA S.
23. Ulusal Nükleer Tıp, İzmir, Turkey, 27 April - 01 May 2011, pp.34, (Summary Text) Sustainable Development
Metrics

Publication

58

Publication (WoS)

30

Publication (Scopus)

30

Citation (WoS)

157

H-Index (WoS)

7

Citation (Scopus)

151

H-Index (Scopus)

6

Citation (Scholar)

63

H-Index (Scholar)

4

Project

5

Thesis Advisory

1

Open Access

9
UN Sustainable Development Goals
SDG 2: GOAL 2: ZERO HUNGER
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING
SDG 5: GOAL 5: GENDER EQUALITY
SDG 8: GOAL 8: DECENT WORK AND ECONOMIC GROWTH
SDG 16: GOAL 16: PEACE, JUSTICE AND STRONG INSTITUTIONS